Does RIPRETINIB Cause Hospitalisation? 280 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 280 reports of Hospitalisation have been filed in association with RIPRETINIB (QINLOCK). This represents 6.3% of all adverse event reports for RIPRETINIB.
280
Reports of Hospitalisation with RIPRETINIB
6.3%
of all RIPRETINIB reports
26
Deaths
280
Hospitalizations
How Dangerous Is Hospitalisation From RIPRETINIB?
Of the 280 reports, 26 (9.3%) resulted in death, 280 (100.0%) required hospitalization.
Is Hospitalisation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIPRETINIB. However, 280 reports have been filed with the FAERS database.
What Other Side Effects Does RIPRETINIB Cause?
Fatigue (582)
Alopecia (517)
Extra dose administered (357)
Death (356)
Underdose (345)
Nausea (292)
Drug ineffective (291)
Disease progression (290)
Neoplasm progression (263)
Constipation (249)
What Other Drugs Cause Hospitalisation?
CLOZAPINE (12,144)
CINACALCET (6,997)
DARBEPOETIN ALFA (5,682)
MACITENTAN (3,414)
APIXABAN (3,315)
ADALIMUMAB (3,033)
DUPILUMAB (2,529)
LENALIDOMIDE (2,241)
DENOSUMAB (2,076)
PALIPERIDONE (2,066)
Which RIPRETINIB Alternatives Have Lower Hospitalisation Risk?
RIPRETINIB vs RISANKIZUMAB
RIPRETINIB vs RISANKIZUMAB-RZAA
RIPRETINIB vs RISDIPLAM
RIPRETINIB vs RISEDRONATE
RIPRETINIB vs RISEDRONIC ACID